Synlogic To Present at Upcoming Investor and Industry Conferences
February 08, 2022 07:00 ET
|
Synlogic, Inc.
CAMBRIDGE, Mass., Feb. 08, 2022 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), a clinical-stage biotechnology company developing medicines for metabolic and immunological diseases through its...
BrainStorm Selected as Buzz of BIO 2020 Winner
December 11, 2019 05:00 ET
|
BrainStorm Cell Therapeutics Inc.
NEW YORK, Dec. 11, 2019 (GLOBE NEWSWIRE) -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leader in the development of innovative autologous cellular therapies for highly debilitating...